Carbometrics
Founded 2018 · 18 employees on LinkedIn · 3 known investors
Find your way into Carbometrics
Carbometrics is developing i-CAM, a continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits used in medical procedures. The product is aimed at clinical settings, with the company engaging clinical collaborators and OEM partners.
Also known as Carbometrics
Investors · 3
.jpeg){kind=logo}
Company profile
researched Aug 2026Carbometrics is a medical device company developing i-CAM, which it describes as a comprehensive continuous metabolic monitor intended for a variety of applications. The company positions the product as a means of providing continuous metabolic insight to support clinical decision-making.
Public information about the company is limited to its own website, which presents the i-CAM monitor and a contact form for inquiries.
▸Full profile — technology, go-to-market
Technology
The company's product, i-CAM, is presented as a continuous metabolic monitor designed to cover a range of applications rather than a single use case.
Go-to-market
Medical and clinical applications.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
In the news
▸Research sources · 1
primary sources listed
- Carbometricscarbometrics.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Carbometrics do?
- Carbometrics is developing i-CAM, a continuous metabolic monitoring device for medical applications.
- Who are Carbometrics's investors?
- Carbometrics's investors include Selvedge Venture, Ada Ventures, Science Creates Ventures.